Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a comprehensive understanding of current treatment practices, addressable patient population, which ...

UCB, a global biopharmaceutical company, today announced three- and four-year data from across the open-label extension (OLE) Phase 3 trials for BIMZELX® (bimekizumab-bkzx) in moderate-to-severe ...

Insomnia Isn’t Just Fatiguing—It Could Be Aging Your Brain Faster: StudyChronic insomnia may accelerate brain aging and ...

Eating more like the Mediterranean—rich in vegetables, legumes, fruits, and olive oil—may do more than just support heart ...

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studiesIcotrokinra also showed ...

The time to onset of action was fastest with IL-17 inhibitors, followed by IL-23, IL-12/23, then PDE-4 and JAK inhibitors for ...

After announcing the iPhone 17, Apple dropped the iPhone 16's price to $699—which means the small differences between it and the $599 iPhone 16e really add up. Here's how to determine which one you ...

Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 Filing ...

Researchers found that long COVID is linked to heavier, longer, and more irregular bleeding without disrupting ovulation.

Experts at Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Soura, today flagged the rising burden of Multiple Sclerosis (MS) in Kashmir. During the weekly Grand Rounds held at the institute, ...

Individuals with Crohn disease and comorbid type 2 diabetes have more unfavorable clinical outcomes and are less likely to ...